Free Access
No Access
Partial Access |
|
Ex-vivo thrombolytic gene therapy for vein graft patency: The frontier for development of selective, localised therapeutic approaches
Christoph E. Hagemeyer; Karlheinz Peter
Atherothrombosis and Vascular Biology, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia
DOI
http://dx.doi.org/10.1160/TH09-06-0343Articles
You've 591 Article(s) in your Basket.
TH 107.5
Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...
TH 107.4
The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....
Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis
Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...